Ruxolitinib for the Treatment of T-Cell Large Granular Lymphocytic Leukemia
- First Posted Date
- 2022-10-24
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Jonathan Brammer
- Target Recruit Count
- 28
- Registration Number
- NCT05592015
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
๐บ๐ธOhio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Oral Azacitidine for the Treatment of Relapsed or Refractory T-cell Large Granular Lymphocytic Leukemia
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-12-02
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Jonathan Brammer
- Target Recruit Count
- 27
- Registration Number
- NCT05141682
- Locations
- ๐บ๐ธ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2021-04-19
- Last Posted Date
- 2024-01-31
- Lead Sponsor
- John Reneau
- Target Recruit Count
- 12
- Registration Number
- NCT04848064
- Locations
- ๐บ๐ธ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
Brentuximab Vedotin and Lenalidomide in Treating Patients With Stage IB-IVB Relapsed or Refractory T-Cell Lymphoma
Phase 2
Active, not recruiting
- Conditions
- Primary Cutaneous Anaplastic Large Cell LymphomaStage III Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent Primary Cutaneous T-Cell Non-Hodgkin LymphomaRecurrent T-Cell Non-Hodgkin LymphomaRefractory Primary Cutaneous T-Cell Non-Hodgkin LymphomaStage I Cutaneous T-Cell Non-Hodgkin LymphomaLymphomatoid PapulosisStage IV Cutaneous T-Cell Non-Hodgkin LymphomaStage II Cutaneous T-Cell Non-Hodgkin Lymphoma
- Interventions
- First Posted Date
- 2018-01-24
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- John Reneau
- Target Recruit Count
- 26
- Registration Number
- NCT03409432
- Locations
- ๐บ๐ธ
Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States
ยฉ Copyright 2024. All Rights Reserved by MedPath